Alejandro Berenguel Senén , Alejandro Gadella Fernández , Juan Godoy López , Javier Borrego Rodríguez , Manuel Gallango Brejano , Pedro Cepas Guillén , Carlos de Cabo Porras , Cristina Morante Perea , Esther Gigante Miravalles , Álvaro Serrano Blanco , Íñigo San-Millán Castrillón , Luis Rodríguez Padial
{"title":"Readaptación funcional basada en ejercicio físico terapéutico en pacientes con COVID persistente (RECOVER)","authors":"Alejandro Berenguel Senén , Alejandro Gadella Fernández , Juan Godoy López , Javier Borrego Rodríguez , Manuel Gallango Brejano , Pedro Cepas Guillén , Carlos de Cabo Porras , Cristina Morante Perea , Esther Gigante Miravalles , Álvaro Serrano Blanco , Íñigo San-Millán Castrillón , Luis Rodríguez Padial","doi":"10.1016/j.recesp.2023.06.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and objectives</h3><p>Postacute COVID syndrome (PACS) is common after acute SARS-CoV-2 infection. One of the most frequent and disabling symptoms is exercise intolerance (EI). Recent evidence suggests that EI in PACS has a peripheral (metabolic-neuromuscular) origin, suggesting that exercise training may be an effective treatment. The aim of this study was to assess the role a therapeutic physical exercise program (TPEP) in PACS with EI.</p></div><div><h3>Methods</h3><p>This single-center, open-label, randomized clinical trial compared an exercise training program (intervention group) with regular physical activity recommendations (control group) in patients with PACS and EI. The intervention group underwent an 8-week TPEP. The primary endpoint was improvement in functional capacity, assessed as the change in peak VO<sub>2</sub>.</p></div><div><h3>Results</h3><p>We included 50 participants with PACS (73% women, mean age 47<!--> <!-->±<!--> <!-->7.1 years). The intervention group showed a 15% improvement in peak VO<sub>2</sub> (peak VO<sub>2</sub> pre- and postintervention: 25.5<!--> <!-->±<!--> <!-->7.7<!--> <!-->mL/kg/min and 29.3<!--> <!-->±<!--> <!-->4.7 mL/kg/min; <em>P</em> <<!--> <!-->.001) and a 13.2% improvement in predicted values (92.1<!--> <!-->±<!--> <!-->14.3% and 108.4<!--> <!-->±<!--> <!-->13.4%; <em>P</em> <<!--> <!-->.001). No significant changes in VO<sub>2</sub> values were observed in the control group. Unlike the control group, the intervention group also showed improvements in all secondary outcomes: quality of life scales, muscle power, maximum inspiratory power, metabolic flexibility, and body fat percentage.</p></div><div><h3>Conclusions</h3><p>The program improved functional capacity in patients with PACS and EI.</p></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":null,"pages":null},"PeriodicalIF":5.9000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista espanola de cardiologia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0300893223002828","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction and objectives
Postacute COVID syndrome (PACS) is common after acute SARS-CoV-2 infection. One of the most frequent and disabling symptoms is exercise intolerance (EI). Recent evidence suggests that EI in PACS has a peripheral (metabolic-neuromuscular) origin, suggesting that exercise training may be an effective treatment. The aim of this study was to assess the role a therapeutic physical exercise program (TPEP) in PACS with EI.
Methods
This single-center, open-label, randomized clinical trial compared an exercise training program (intervention group) with regular physical activity recommendations (control group) in patients with PACS and EI. The intervention group underwent an 8-week TPEP. The primary endpoint was improvement in functional capacity, assessed as the change in peak VO2.
Results
We included 50 participants with PACS (73% women, mean age 47 ± 7.1 years). The intervention group showed a 15% improvement in peak VO2 (peak VO2 pre- and postintervention: 25.5 ± 7.7 mL/kg/min and 29.3 ± 4.7 mL/kg/min; P < .001) and a 13.2% improvement in predicted values (92.1 ± 14.3% and 108.4 ± 13.4%; P < .001). No significant changes in VO2 values were observed in the control group. Unlike the control group, the intervention group also showed improvements in all secondary outcomes: quality of life scales, muscle power, maximum inspiratory power, metabolic flexibility, and body fat percentage.
Conclusions
The program improved functional capacity in patients with PACS and EI.
期刊介绍:
Revista Española de Cardiología, Revista bilingüe científica internacional, dedicada a las enfermedades cardiovasculares, es la publicación oficial de la Sociedad Española de Cardiología.